Losartan and Galafold drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Losartan (losartan potassium) and Galafold (migalastat hydrochloride). Common drug interactions include autism spectrum disorder among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Losartan and Galafold. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Losartan?

Losartan has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 177,692 Losartan users. Check the latest studies of Losartan.

What is Galafold?

Galafold has active ingredients of migalastat hydrochloride. eHealthMe is studying from 442 Galafold users. Check the latest studies of Galafold.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 21, 2026

19 people who take Losartan and Galafold together, and have interactions are studied.

Losartan and Galafold drug interactions.

What are the common drug interactions of Losartan and Galafold, by gender? *:

female:

  1. Autism spectrum disorder (developmental disabilities that can cause significant social, communication and behavioural challenges)
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  4. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  5. Crying
  6. Fall
  7. Loss of consciousness
  8. Abdominal pain
  9. Acute respiratory distress syndrome
  10. Dizziness

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Cataract (clouding of the lens inside the eye)
  3. Diarrhoea
  4. Prostate cancer
  5. Angiopathy (generic term for a disease of the blood vessels)
  6. Chest discomfort
  7. Pain
  8. Volume blood decreased
  9. Hydrocephalus (water on the brain)

What are the common drug interactions of Losartan and Galafold, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain
  2. Headache (pain in head)
  3. Heart rate increased
  4. Nausea (feeling of having an urge to vomit)

30-39:

n/a

40-49:

  1. Anger
  2. Autism spectrum disorder (developmental disabilities that can cause significant social, communication and behavioural challenges)
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  5. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  6. Crying
  7. Panic attack
  8. Panic reaction

50-59:

  1. Prostate cancer

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Cataract (clouding of the lens inside the eye)
  3. Fall
  4. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  5. Loss of consciousness
  6. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  7. Pneumonia
  8. Staphylococcal infection (an infection with staphylococcus bacteria)
  9. Diarrhoea
  10. Angiopathy (generic term for a disease of the blood vessels)

What are the existing conditions these people have? *

  1. Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 19 people, 100.00%
  2. Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 4 people, 21.05%
  3. Dysmenorrhea (painful menstruation): 3 people, 15.79%
  4. Lipidosis (disorder of lipid metabolism involving abnormal accumulation of lipids in the reticuloendothelial cells): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan and Galafold?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Losartan and Galafold:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Losartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Galafold:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Losartan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Galafold and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium and migalastat hydrochloride (the active ingredients of Losartan and Galafold, respectively), and Losartan and Galafold (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: